A comparison of low-dose and high-dose protocols of vaginal misoprostol for second trimester termination of pregnancy

dc.contributor.buuauthorÖzerkan, Kemal
dc.contributor.buuauthorOcakoğlu, Gökhan
dc.contributor.buuauthorRehimli, S.
dc.contributor.buuauthorUncu, Gürkan
dc.contributor.buuauthorDevelioğlu, Osman H.
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kadın Hastalıkları ve Doğum Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Biyoistatistik Anabilim Dalı.tr_TR
dc.contributor.researcheridAAH-9791-2021tr_TR
dc.contributor.researcheridAAH-5180-2021tr_TR
dc.contributor.scopusid6603345841tr_TR
dc.contributor.scopusid15832295800tr_TR
dc.contributor.scopusid25936644900tr_TR
dc.contributor.scopusid6603716169tr_TR
dc.contributor.scopusid6701315440tr_TR
dc.date.accessioned2022-03-04T06:15:07Z
dc.date.available2022-03-04T06:15:07Z
dc.date.issued2009
dc.description.abstractSixty patients were randomized to low-dose and high-dose groups, receiving a maximum total dose 1400 g of misoprostol by the vaginal route to compare the efficacy of the protocols for second trimester termination of pregnancy. Outcome measures to be compared between the groups were Success rates, time to termination, blood loss, complications and side-effects. Yet time to termination was significantly shorter in the high-close than in the low-dose group (923 +/- 571 vs 1307 +/- 828 min; p < 0.05). The distance between the internal cervical os and the placenta was positively correlated with the duration of the termination process (r = 0.508, p < 0.001). Induction to the fetal expulsion period is shorter with the higher dose without any significant increase in morbidity. A shorter distance between the internal cervical os and the placenta may forecast a shorter termination process.en_US
dc.identifier.citationÖzerkan, K. vd. (2009). "A comparison of low-dose and high-dose protocols of vaginal misoprostol for second trimester termination of pregnancy". Clinical and Experimental Obstetrics and Gynecology, 36(4), 245-247.en_US
dc.identifier.endpage247tr_TR
dc.identifier.issn0390-6663
dc.identifier.issue4tr_TR
dc.identifier.pubmed20101858tr_TR
dc.identifier.scopus2-s2.0-73949097273tr_TR
dc.identifier.startpage245tr_TR
dc.identifier.urihttp://hdl.handle.net/11452/24818
dc.identifier.volume36tr_TR
dc.identifier.wos000272203800015
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherIMR Pressen_US
dc.relation.journalClinical and Experimental Obstetrics and Gynecologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInduced abortionen_US
dc.subjectMisoprostolen_US
dc.subjectPregnancyen_US
dc.subjectSecond trimesteren_US
dc.subjectRandomized controlled-trialen_US
dc.subject2nd-trimester pregnancyen_US
dc.subjectIntravaginal misoprostolen_US
dc.subjectOral misoprostolen_US
dc.subject2 regimensen_US
dc.subjectObstetrics & gynecologyen_US
dc.subject.emtreeMisoprostolen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAnalytical parametersen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBleedingen_US
dc.subject.emtreeClinical examinationen_US
dc.subject.emtreeClinical featureen_US
dc.subject.emtreeClinical protocolen_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeControlled clinical trialen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeDrug dose comparisonen_US
dc.subject.emtreeDrug efficacyen_US
dc.subject.emtreeEchographyen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeLow drug doseen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMorbidityen_US
dc.subject.emtreeOperation durationen_US
dc.subject.emtreeOutcome assessmenten_US
dc.subject.emtreePlacentaen_US
dc.subject.emtreePredictionen_US
dc.subject.emtreePregnancy terminationen_US
dc.subject.emtreeRandomized controlled trialen_US
dc.subject.emtreeSecond trimester pregnancyen_US
dc.subject.meshAbortifacient agents, nonsteroidalen_US
dc.subject.meshAbortion, induceden_US
dc.subject.meshDrug administration scheduleen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMisoprostolen_US
dc.subject.meshPregnancyen_US
dc.subject.meshPregnancy trimester, seconden_US
dc.subject.scopusInduced Labor; Pregnancy; Misoprostolen_US
dc.subject.wosObstetrics & gynecologyen_US
dc.titleA comparison of low-dose and high-dose protocols of vaginal misoprostol for second trimester termination of pregnancyen_US
dc.typeArticle
dc.wos.quartileQ4en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: